Published in
Wiley, Pharmaceutical Statistics, 2(18), p. 166-183, 2018
DOI: 10.1002/pst.1915
Links
Tools
On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies
Journal article published in 2018 by
Steffen Unkel 
,
Marjan Amiri ,
Norbert Benda ,
Jan Beyersmann,
Dietrich Knoerzer,
Katrin Kupas,
Frank Langer,
Friedhelm Leverkus,
Anja Loos,
Claudia Ose,
Tanja Proctor,
Claudia Schmoor,
Carsten Schwenke,
Guido Skipka,
Kristina Unnebrink
and other authors.
,
Marjan Amiri ,
Norbert Benda ,
Jan Beyersmann,
Dietrich Knoerzer,
Katrin Kupas,
Frank Langer,
Friedhelm Leverkus,
Anja Loos,
Claudia Ose,
Tanja Proctor,
Claudia Schmoor,
Carsten Schwenke,
Guido Skipka,
Kristina Unnebrink
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 